Centene Corporation (0HVB.L)
USD 59.65
(2.35%)
USD 59.65
(2.35%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 17.69 Billion USD | -1.33% |
| 2022 | 17.93 Billion USD | -3.41% |
| 2021 | 18.57 Billion USD | 11.32% |
| 2020 | 16.68 Billion USD | 22.32% |
| 2019 | 13.63 Billion USD | 105.14% |
| 2018 | 6.64 Billion USD | 41.6% |
| 2017 | 4.69 Billion USD | 0.95% |
| 2016 | 4.65 Billion USD | 282.48% |
| 2015 | 1.21 Billion USD | 39.13% |
| 2014 | 874 Million USD | 31.23% |
| 2013 | 666 Million USD | 24.37% |
| 2012 | 535.48 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 17.51 Billion USD | -2.09% |
| 2024 Q1 | 17.88 Billion USD | 1.0% |
| 2024 Q3 | 17.49 Billion USD | -0.11% |
| 2023 Q3 | 17.88 Billion USD | -0.04% |
| 2023 Q2 | 17.89 Billion USD | -1.79% |
| 2023 Q1 | 18.22 Billion USD | 1.59% |
| 2023 FY | 17.71 Billion USD | -1.27% |
| 2023 Q4 | 17.71 Billion USD | -1.0% |
| 2022 Q3 | 18.08 Billion USD | -2.02% |
| 2022 Q2 | 18.45 Billion USD | -0.99% |
| 2022 Q1 | 18.64 Billion USD | 0.37% |
| 2022 FY | 17.93 Billion USD | -3.41% |
| 2022 Q4 | 17.93 Billion USD | -0.81% |
| 2021 Q1 | 16.69 Billion USD | 1.0% |
| 2021 Q2 | 16.53 Billion USD | -0.95% |
| 2021 FY | 18.57 Billion USD | 11.32% |
| 2021 Q3 | 18.59 Billion USD | 12.45% |
| 2021 Q4 | 18.57 Billion USD | -0.12% |
| 2020 Q1 | 17.03 Billion USD | 25.9% |
| 2020 FY | 16.68 Billion USD | 22.32% |
| 2020 Q3 | 16.6 Billion USD | 0.19% |
| 2020 Q2 | 16.56 Billion USD | -2.71% |
| 2020 Q4 | 16.52 Billion USD | -0.43% |
| 2019 Q2 | 6.93 Billion USD | 2.11% |
| 2019 Q1 | 6.78 Billion USD | 1.36% |
| 2019 FY | 13.63 Billion USD | 105.14% |
| 2019 Q4 | 13.52 Billion USD | 96.78% |
| 2019 Q3 | 6.87 Billion USD | -0.81% |
| 2018 Q1 | 5.29 Billion USD | 11.43% |
| 2018 FY | 6.64 Billion USD | 41.6% |
| 2018 Q3 | 6.52 Billion USD | 1.79% |
| 2018 Q4 | 6.69 Billion USD | 2.6% |
| 2018 Q2 | 6.41 Billion USD | 21.15% |
| 2017 Q3 | 4.77 Billion USD | 0.02% |
| 2017 Q4 | 4.74 Billion USD | -0.44% |
| 2017 Q1 | 4.71 Billion USD | 0.04% |
| 2017 Q2 | 4.76 Billion USD | 1.15% |
| 2017 FY | 4.69 Billion USD | 0.95% |
| 2016 Q1 | 4.28 Billion USD | 251.89% |
| 2016 FY | 4.65 Billion USD | 282.48% |
| 2016 Q4 | 4.71 Billion USD | 25.88% |
| 2016 Q3 | 3.74 Billion USD | 2.6% |
| 2016 Q2 | 3.64 Billion USD | -14.86% |
| 2015 Q3 | 1.27 Billion USD | 11.54% |
| 2015 Q2 | 1.14 Billion USD | 1.69% |
| 2015 Q1 | 1.12 Billion USD | 28.72% |
| 2015 FY | 1.21 Billion USD | 39.13% |
| 2015 Q4 | 1.21 Billion USD | -4.55% |
| 2014 Q3 | 950.97 Million USD | 7.47% |
| 2014 Q2 | 884.89 Million USD | 9.12% |
| 2014 Q1 | 810.97 Million USD | 21.77% |
| 2014 FY | 874 Million USD | 31.23% |
| 2014 Q4 | 874 Million USD | -8.09% |
| 2013 Q4 | 666 Million USD | 28.59% |
| 2013 Q2 | 548.47 Million USD | 2.95% |
| 2013 Q3 | 517.93 Million USD | -5.57% |
| 2013 Q1 | 532.73 Million USD | -0.51% |
| 2013 FY | 666 Million USD | 24.37% |
| 2012 FY | 535.48 Million USD | 0.0% |
| 2012 Q4 | 535.48 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Phreesia, Inc. | 2.04 Million USD | -863687.213% |
| Accuray Incorporated | 164.4 Million USD | -10665.815% |
| Align Technology, Inc. | 96.96 Million USD | -18152.413% |
| Elevance Health Inc. | 23.24 Billion USD | 23.862% |
| AxoGen, Inc. | 46.6 Million USD | -37878.242% |
| Boston Scientific Corporation | 8.56 Billion USD | -106.619% |
| CVS Health Corporation | 74.67 Billion USD | 76.298% |
| Cardinal Health, Inc. | 4.58 Billion USD | -286.188% |
| DaVita Inc. | 8.05 Billion USD | -119.829% |
| HCA Healthcare, Inc. | 36.62 Billion USD | 51.679% |
| Hologic, Inc. | 2.49 Billion USD | -608.782% |
| Humana Inc. | 10.21 Billion USD | -73.299% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | -2741.465% |
| Laboratory Corporation of America Holdings | 4.05 Billion USD | -336.506% |
| Masimo Corporation | 871.7 Million USD | -1930.4% |
| McKesson Corporation | 5.45 Billion USD | -224.693% |
| Patterson Companies, Inc. | 328.91 Million USD | -5281.091% |
| Quest Diagnostics Incorporated | 4.41 Billion USD | -301.338% |
| ResMed Inc. | 697.31 Million USD | -2438.172% |
| Henry Schein, Inc. | 1.93 Billion USD | -815.623% |
| Teladoc Health, Inc. | 1.58 Billion USD | -1019.11% |
| Universal Health Services, Inc. | 4.71 Billion USD | -275.286% |
| Veeva Systems Inc. | 46.44 Million USD | -38010.721% |
| Baxter International Inc. | 11.06 Billion USD | -59.969% |
| Becton, Dickinson and Company | 14.73 Billion USD | -20.091% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 21657.856% |
| Danaher Corporation | 17.66 Billion USD | -0.215% |
| Stryker Corporation | 10.9 Billion USD | -62.361% |
| Medtronic plc | 23.87 Billion USD | 25.874% |